First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
January 17, 2024 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
January 05, 2024 16:01 ET
|
Barinthus Biotherapeutics
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024
January 04, 2024 06:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program
December 27, 2023 06:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
December 18, 2023 06:00 ET
|
First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
August 23, 2023 07:30 ET
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
8.4% CAGR for Capsule Endoscopy Market Size Worth $757.51 Million by 2028 – Deep Dive Analysis of 18+ Countries across 5 Key Regions, 50+ Companies Scrutinized | The Insight Partners
March 09, 2023 08:51 ET
|
The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Capsule Endoscopy Market Size, Share, Growth and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By...
L’Association canadienne de la maladie cœliaque rétablit les faits
May 03, 2021 10:53 ET
|
l'Association canadienne de la maladie cœliaque
TORONTO, 03 mai 2021 (GLOBE NEWSWIRE) -- Le mois de mai est celui de la sensibilisation à la maladie cœliaque et l'Association canadienne de la maladie cœliaque (ACMC) rétablit les faits pour les...
Canadian Celiac Association is Setting the Record Straight
May 03, 2021 10:53 ET
|
Canadian Celiac Association
TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- May is Celiac Awareness Month and the Canadian Celiac Association (CCA) is setting the record straight for Canadians suffering with celiac disease. An...
Gluten-Free Campaign Asks, “How Do You Sandwich?”
May 05, 2020 09:37 ET
|
Canadian Celiac Association
TORONTO, May 05, 2020 (GLOBE NEWSWIRE) -- The Canadian Celiac Association (CCA) wants to know what Canadians put between their buns. Today, it is launching How Do You Sandwich? – a month-long social...